chr1-45509214-G-T

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM4BP6BS1BS2

The NM_015506.3(MMACHC):​c.848G>T​(p.Ter283LeuextTer14) variant causes a stop lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00023 in 1,613,930 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. *283*) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00029 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00022 ( 4 hom. )

Consequence

MMACHC
NM_015506.3 stop_lost

Scores

1
2
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:5

Conservation

PhyloP100: 1.35
Variant links:
Genes affected
MMACHC (HGNC:24525): (metabolism of cobalamin associated C) The exact function of the protein encoded by this gene is not known, however, its C-terminal region shows similarity to TonB, a bacterial protein involved in energy transduction for cobalamin (vitamin B12) uptake. Hence, it is postulated that this protein may have a role in the binding and intracellular trafficking of cobalamin. Mutations in this gene are associated with methylmalonic aciduria and homocystinuria type cblC. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PM4
Stoplost variant in NM_015506.3 Downstream stopcodon found after 293 codons.
BP6
Variant 1-45509214-G-T is Benign according to our data. Variant chr1-45509214-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 197306.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=3, Benign=3}.
BS1
Variant frequency is greater than expected in population amr. gnomad4_exome allele frequency = 0.000224 (328/1461786) while in subpopulation AMR AF= 0.00727 (325/44720). AF 95% confidence interval is 0.00662. There are 4 homozygotes in gnomad4_exome. There are 114 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 4 AR,Digenic gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MMACHCNM_015506.3 linkuse as main transcriptc.848G>T p.Ter283LeuextTer14 stop_lost 4/4 ENST00000401061.9
MMACHCNM_001330540.2 linkuse as main transcriptc.677G>T p.Ter226LeuextTer14 stop_lost 4/4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MMACHCENST00000401061.9 linkuse as main transcriptc.848G>T p.Ter283LeuextTer14 stop_lost 4/42 NM_015506.3 P1
MMACHCENST00000616135.1 linkuse as main transcriptc.677G>T p.Ter226LeuextTer14 stop_lost 4/52

Frequencies

GnomAD3 genomes
AF:
0.000289
AC:
44
AN:
152026
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00275
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000480
GnomAD3 exomes
AF:
0.00112
AC:
277
AN:
248412
Hom.:
4
AF XY:
0.000756
AC XY:
102
AN XY:
135006
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00803
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000224
AC:
328
AN:
1461786
Hom.:
4
Cov.:
32
AF XY:
0.000157
AC XY:
114
AN XY:
727188
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00727
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.000289
AC:
44
AN:
152144
Hom.:
0
Cov.:
32
AF XY:
0.000309
AC XY:
23
AN XY:
74382
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00275
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.000475
Alfa
AF:
0.00000872
Hom.:
0
Bravo
AF:
0.000661
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.000770
AC:
93

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Cobalamin C disease Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitterclinical testingCounsylJan 10, 2017- -
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvityMar 30, 2023- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 27, 2024- -
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jan 26, 2015- -
Benign, criteria provided, single submitterclinical testingGeneDxFeb 08, 2021- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpFeb 24, 2022Variant summary: MMACHC c.848G>T (p.X283LeuextX14) changes the termination codon and is predicted to lead to an extended protein with additional amino acids added to the normal C-terminus. MMACHC c.848G>T (p.X283LeuextX14) causes a frameshift which results in an extension of the protein. The variant allele was found at a frequency of 0.0011 in 248412 control chromosomes, predominantly at a frequency of 0.008 within the Latino subpopulation in the gnomAD database, including 4 homozygotes. The observed variant frequency within Latino control individuals in the gnomAD database is approximately 3 fold of the estimated maximal expected allele frequency for a pathogenic variant in MMACHC causing Methylmalonic Acidemia With Homocystinuria phenotype (0.0032), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Latino origin. To our knowledge, no occurrence of c.848G>T in individuals affected with Methylmalonic Acidemia With Homocystinuria and no experimental evidence demonstrating its impact on protein function have been reported. Five ClinVar submitters (evaluation after 2014) cite the variant as benign (n=3) and uncertain significance (n=2). Based on the evidence outlined above, the variant was classified as benign. -
MMACHC-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesSep 23, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Methylmalonic acidemia with homocystinuria cblC Benign:1
Benign, no assertion criteria providedclinical testingNatera, Inc.Apr 30, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.51
CADD
Benign
14
DANN
Benign
0.76
Eigen
Pathogenic
0.70
Eigen_PC
Uncertain
0.45
FATHMM_MKL
Uncertain
0.82
D
MutationTaster
Benign
1.0
N
Vest4
0.082
GERP RS
3.5

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201025783; hg19: chr1-45974886; API